{"id":432809,"date":"2019-09-26T11:28:01","date_gmt":"2019-09-26T11:28:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=432809"},"modified":"2019-09-26T11:28:01","modified_gmt":"2019-09-26T11:28:01","slug":"creative-diagnostics-launches-nano-secondary-antibodies-for-bioapplications","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/creative-diagnostics-launches-nano-secondary-antibodies-for-bioapplications_432809.html","title":{"rendered":"Creative Diagnostics Launches Nano Secondary Antibodies for Bio-Applications"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1569476981.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Creative Diagnostics Launches Nano Secondary Antibodies for Bio-Applications\" src=\"https:\/\/www.abnewswire.com\/uploads\/1569476981.jpeg\" alt=\"Creative Diagnostics Launches Nano Secondary Antibodies for Bio-Applications\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<p style=\"text-align: justify;\">As a global&nbsp;leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics introduces <a rel=\"nofollow\" title=\"Nano Secondary Antibodies\" href=\"https:\/\/www.creative-diagnostics.com\/news-nano-secondary-antibodies-76.htm\" target=\"_blank\">nano secondary antibodies<\/a> with high affinity and specificity for global researchers. The new nano secondary antibodies against rabbit and mouse IgG are now available, including Recombinant Alpaca Anti-Rabbit IgG monoclonal antibody, Recombinant Alpaca Anti-Mouse IgG2b Fc monoclonal antibody, and Recombinant Alpaca Anti-Mouse IgG3 Fab monoclonal antibody, which are fully validated to be applied in IP, ELISA, IHC, WB, recombinant VHH, and western blot.<\/p>\n<p style=\"text-align: justify;\">The nano secondary antibody&nbsp;offers&nbsp;increased sensitivity due to multiple binding to a single primary antibody. In addition, secondary antibodies&nbsp;can be used with any primary antibodies&nbsp;with the same isotype and target species. Moreover, most primary antibodies are produced in just a few host animal species,&nbsp;making them economical to develop a relatively small number of ready-to-use secondary antibodies that suit many methods and detection systems.<\/p>\n<p style=\"text-align: justify;\">Creative Diagnostics now offers a wide range of species-specific <a rel=\"nofollow\" title=\"Secondary Antibodies\" href=\"https:\/\/www.creative-diagnostics.com\/Secondary-Antibodies.htm\" target=\"_blank\">secondary antibodies<\/a> with a variety of conjugated labels. Its&nbsp;affinity purified secondary antibodies are available for whole Ig classes and antibody fragments such as the Fc or Fab regions, with the lowest non-specific binding. The conjugated secondary antibodies also have numerous applications including flow cytometry, immunohistochemistry, Western blotting, and more.<\/p>\n<p style=\"text-align: justify;\">&#8220;The nano secondary antibodies products we currently offered can also be used in&nbsp;immunofluorescence, and super-resolution microscopy. It has many advantages, such as better tissue penetration and small epitope-label displacement for higher resolution, and our <a rel=\"nofollow\" title=\"Antibodies\" href=\"https:\/\/www.creative-diagnostics.com\/Antibodies.htm\" target=\"_blank\">antibodies<\/a> are featured with high lot-to-lot consistency. Also our one-step immunostaining protocol saves researchers&#8217; time and cost. All of this makes us more competitive on the market to help us continually provide our clients better services,&#8221; says Dr. Jessica Waldorf, chief scientific officer of R&amp;D department of Creative Diagnostics.<\/p>\n<p style=\"text-align: justify;\">&#8220;We are striving to make our customers satisfied to fight&nbsp;against any scientific challenges. After launching these new products, we&#8217;re glad to know researchers in the&nbsp;life science&nbsp;field&nbsp;move forward with research&nbsp;through Creative Diagnostics. By offering a wide range of high quality antibodies validated for use in multiplexed assays, we guarantee that&nbsp;researchers&nbsp;always have access to our best antibodies products and related services,&#8221; stated Prof. Mike Knuth, M.D., the chief scientific officer of R&amp;D department of Creative Diagnostics.<\/p>\n<p style=\"text-align: justify;\">If you want to know more information about&nbsp;nano secondary antibodies&nbsp;or other&nbsp;products, please contact Creative Diagnostics at 1-631-619-7922 or email to contact@creative-diagnostics.com<\/p>\n<p style=\"text-align: justify;\"><strong>About Creative Diagnostics<\/strong><\/p>\n<p style=\"text-align: justify;\">Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&amp;D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers&#8217; assay development and manufacturing needs.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/creative-diagnostics.com_17257.html\" rel=\"nofollow\">Creative Diagnostics<\/a><br \/><strong>Contact Person:<\/strong> Thomas Schmitt<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=creative-diagnostics-launches-nano-secondary-antibodies-for-bioapplications\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 1-631-619-7922<br \/><strong>Address:<\/strong>45-1 Ramsey Road  <br \/><strong>City:<\/strong> Shirley<br \/><strong>State:<\/strong> NY<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.creative-diagnostics.com\" target=\"_blank\" rel=\"nofollow\">www.creative-diagnostics.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.creative-diagnostics.com\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=creative-diagnostics-launches-nano-secondary-antibodies-for-bioapplications\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As a global&nbsp;leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics introduces nano secondary antibodies with high affinity and specificity for global researchers. The new nano secondary antibodies against rabbit and mouse IgG are now &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/creative-diagnostics-launches-nano-secondary-antibodies-for-bioapplications_432809.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,423,420,411],"tags":[],"class_list":["post-432809","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Science","category-Technology"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/432809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=432809"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/432809\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=432809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=432809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=432809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}